Prosight Management, LP

Holdings History for Rein Therapeutics, Inc. - Common Stock, $0.001 par value (RNTX)

Symbol: RNTX on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.11%	-0.03%	$513,416	442,600	-125,298	-22%	$1.16	Q4 2025
30 Sep 2025	0.16%	+0.04%	$650,243	567,898	+139,979	+33%	$1.14	Q3 2025
30 Jun 2025	0.15%	-0%	$599,087	427,919	-2,081	-0.48%	$1.40	Q2 2025
31 Mar 2025	0.25%	+0.01%	$761,100	430,000	+25,021		$1.77	Q1 2025
31 Dec 2024	0.26%	+0.02%	$931,452	404,979	+32,822	+8.8%	$2.30	Q4 2024
30 Sep 2024	0.33%	+0.1%	$1,317,436	372,157	+107,157	+40%	$3.54	Q3 2024
30 Jun 2024	0.22%	+0.2%	$734,050	265,000	+265,000	NEW	$2.77	Q2 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.